Drug Table - Antimetabolites Flashcards
Antimetabolites in general
Structural analogs of folic acid or of the
purine/pyramidine bases found in DNA; act
in S-phase (cell cycle specific)
Antimetabolites list
Methotrexate (Trexall) Pemetrexed (Alimta) 5-Fluorouracil (5-FU, Carac) Cytarabine (AraC, Depocyt) Gemcitabine (dFdC, Gemzar) 6-Mercaptopurine (Purinethol)
Methotrexate (Trexall) class
Folate analogs
Methotrexate (Trexall) mech
Inhibits dihydrofolate reductase (DHFR), which converts dietary folate to tetrahydrofolate (THF) needed for thymidine and purine synthesis; given orally or intrathecally
Methotrexate (Trexall) Therapeutics
Childhood ALL and choriocarcinoma; combination therapy for Burkitt's lymphoma and carcinomas of breast, ovary, head and neck, and bladder; administered intrathecally for meningeal leukemia and meningeal metastases of tumors (can't cross BBB); high-dose for osteosarcoma
Methotrexate (Trexall) Imp Side effects
Renal toxicity (crystallization in urine at high doses), hepatotoxicity (long-term, fibrosis/cirrhosis), reproductive (defective oogenesis or spermatogenesis, abortion)
Methotrexate (Trexall) Other side effects
Bone marrow (myelosuppression, spontaneous hemorrhage); GI toxicity (oral ulceration, stomatitis)
Methotrexate (Trexall) Misc
Can use leucovorin to prevent toxic
effects of MTX, as healthy cells can
take it up a lot better than tumor cells
Pemetrexed (Alimta) class
Folate analogs
Pemetrexed (Alimta) Mech
Polyglutamate forms that inhibit THFdependent enzymes (e.g., DHFR, TS); metabolized to polyglutamate forms that inhibit THF-dependent enzymes (e.g., DHFR, thymidylate synthase (TS))
Pemetrexed (Alimta) Therapeutics
Colon cancer, mesothelioma, non-small
cell lung cancer, pancreatic cancer
5-Fluorouracil (5-FU, Carac) class
Pyramidine analogs
5-Fluorouracil (5-FU, Carac) Mech
5-FU is converted to active metabolites: 5-
FdUMP inhibits TS; 5-FdUTP incorporates
into RNA & interferes with RNA function;
prodrug [capesitabine] ribosylated and phophosrylated into
5-FdUMP
5-Fluorouracil (5-FU, Carac) Therapeutics
Combination therapy for breast,
colorectal, gastric, head and neck,
cervical and pancreatic cancer;
topically for basal cell carcinoma
5-Fluorouracil (5-FU, Carac) Imp Side Effects
Hand-foot syndrome (erythema,
sensitivity of palms and soles),
cardiac toxicity (acute chest pains)